logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers who have significant controls over the individuals in focus are always inapplicable. The offspring entities and appointments are those entities that the individuals in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Offsprings
Parent entities and officers
Inapplicable
parent relation
Individuals in focus

Lee, Richard Michael

    Related profiles found in government register
  • Lee, Richard Michael
    British born in December 1981

    Resident in England

    Registered addresses and corresponding companies
  • Lee, Richard Michael
    born in December 1981

    Resident in England

    Registered addresses and corresponding companies
  • Mr Richard Michael Lee
    British born in December 1981

    Resident in England

    Registered addresses and corresponding companies
  • Lee, Richard Michael
    British born in December 1981

    Resident in United Kingdom

    Registered addresses and corresponding companies
  • Mr Richard Michael Lee
    British born in December 1981

    Resident in United Kingdom

    Registered addresses and corresponding companies
child relation
Offspring entities and appointments 16
  • 1
    CALSTAR BIO LIMITED
    13079329
    Dissolved Corporate (6 parents)
    Officer
    2020-12-14 ~ dissolved
    IIF 4 - Director → ME
    Person with significant control
    2020-12-14 ~ 2020-12-21
    IIF 8 - Right to appoint or remove directors → OE
    IIF 8 - Ownership of shares – 75% or more → OE
    IIF 8 - Ownership of voting rights - 75% or more → OE
  • 2
    CASSINI BIO LIMITED
    16906047
    Active Corporate (3 parents)
    Officer
    2025-12-12 ~ 2026-01-19
    IIF 13 - Director → ME
  • 3
    CENTESSA PHARMACEUTICALS (UK) LIMITED - now
    CENTESSA LIMITED
    - 2022-11-22 13040752
    UNITED MEDICINES BIOPHARMA (MIDCO) LIMITED
    - 2021-02-17 13040752 12973576
    Active Corporate (14 parents, 8 offsprings)
    Officer
    2020-11-24 ~ 2021-02-19
    IIF 1 - Director → ME
  • 4
    CENTESSA PHARMACEUTICALS LIMITED - now
    CENTESSA PHARMACEUTICALS PLC - 2026-09-07
    CENTESSA PHARMACEUTICALS LIMITED - 2021-05-14
    UNITED MEDICINES BIOPHARMA LIMITED
    - 2021-02-17 12973576 13040752
    Active Corporate (17 parents, 9 offsprings)
    Officer
    2020-10-26 ~ 2021-01-29
    IIF 5 - Director → ME
    Person with significant control
    2020-10-26 ~ 2021-01-29
    IIF 9 - Ownership of shares – 75% or more → OE
    IIF 9 - Ownership of voting rights - 75% or more → OE
    IIF 9 - Right to appoint or remove directors → OE
  • 5
    FIG THERAPEUTICS LIMITED
    15653158
    Active Corporate (4 parents)
    Officer
    2024-04-16 ~ 2024-05-13
    IIF 12 - Director → ME
  • 6
    GRAEGIS PHARMACEUTICALS LIMITED
    13680871
    Liquidation Corporate (10 parents)
    Officer
    2021-10-14 ~ 2023-05-10
    IIF 11 - Director → ME
    Person with significant control
    2021-10-14 ~ 2021-12-01
    IIF 20 - Right to appoint or remove directors → OE
    IIF 20 - Ownership of voting rights - 75% or more → OE
    IIF 20 - Ownership of shares – 75% or more → OE
  • 7
    MEDICXI VENTURES (UK) LLP
    OC402437
    Active Corporate (9 parents)
    Officer
    2021-01-01 ~ now
    IIF 6 - LLP Designated Member → ME
  • 8
    PELEUS THERAPEUTICS LIMITED
    13076921
    Dissolved Corporate (6 parents)
    Officer
    2020-12-11 ~ dissolved
    IIF 3 - Director → ME
    Person with significant control
    2020-12-11 ~ 2020-12-21
    IIF 7 - Ownership of voting rights - 75% or more → OE
    IIF 7 - Ownership of shares – 75% or more → OE
    IIF 7 - Right to appoint or remove directors → OE
  • 9
    PETALION THERAPEUTICS LIMITED
    15363420
    Active Corporate (6 parents)
    Officer
    2023-12-20 ~ 2024-04-06
    IIF 10 - Director → ME
  • 10
    PLEXA THERAPEUTICS LIMITED - now
    VINCA THERAPEUTICS LIMITED
    - 2026-09-25 17335176
    Active Corporate (3 parents)
    Officer
    2026-07-13 ~ 2026-08-21
    IIF 17 - Director → ME
  • 11
    PODIUM BIO LIMITED
    13537907
    Liquidation Corporate (6 parents)
    Officer
    2021-07-29 ~ now
    IIF 2 - Director → ME
  • 12
    TACTIX BIO LIMITED - now
    MEDICXI HOLDCO 1 LIMITED
    - 2026-01-26 16891632
    Active Corporate (3 parents)
    Officer
    2025-12-04 ~ 2026-01-19
    IIF 16 - Director → ME
  • 13
    TESSERIS THERAPEUTICS LIMITED
    15156026
    Dissolved Corporate (4 parents)
    Officer
    2023-09-22 ~ dissolved
    IIF 15 - Director → ME
  • 14
    THEOREM BIOPHARMACEUTICALS LIMITED
    - now 16513869
    ORTHUS PHARMACEUTICALS LIMITED
    - 2025-10-29 16513869
    Active Corporate (4 parents)
    Officer
    2025-06-17 ~ 2025-12-16
    IIF 18 - Director → ME
  • 15
    ULTRAHUMAN LIMITED
    09885211
    Dissolved Corporate (10 parents)
    Officer
    2023-06-30 ~ dissolved
    IIF 19 - Director → ME
  • 16
    VIMELA THERAPEUTICS LIMITED
    13611487
    Liquidation Corporate (10 parents)
    Officer
    2021-09-09 ~ 2021-11-30
    IIF 14 - Director → ME
    Person with significant control
    2021-09-09 ~ 2021-11-30
    IIF 21 - Ownership of voting rights - 75% or more → OE
    IIF 21 - Ownership of shares – 75% or more → OE
    IIF 21 - Right to appoint or remove directors → OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 30 October 2026 and licensed under the Open Government Licence v3.0.